Pivotal phase 2 study of Obinutuzumab as Monotherapy or in combination with Zanubrutinib

 IMAGE   06/2020

Pivotal phase 2 study of Obinutuzumab as Monotherapy or in combination with Zanubrutinib in R/R FL

Rating

Rate this publication